| Antigen: |
CD45R |
| Relevance: |
CD45 is a transmembrane tyrosine phosphatase that is present on all leukocytes. CD45 regulates the threshold of T cell antigen receptor (TCR) signaling through dephosphorylation of protein tyrosine kinases (e.g. Lck and Fyn). CD45R and CD45RO are two of multiple CD45 isoforms generated by alternative splicing. CD45R is found on B lymphocyte and T lymphocyte subsets. CD45RO is present on 50% of T cells, most granulocytes and monocytes and most mature T cell tumours. 351C5 can be used in typing of leukaemias and lymphomas and in research on functional subsets of B and T cells. 351C5 can be used in typing of leukaemias and lymphomas and in research on functional subsets of B and T cells. |
| Clone: |
351C5 |
| Subclass: |
IgM |
| Applications: |
Immunoprecipitation, FACS, Immunohistochemistry (Frozen) |
| Immunogen: |
Raji cells |
| Reactivity: |
Human |
| Species raised in: |
- |
| Fusion partner: |
- |
| Recommended growth conditions: |
DMEM + 5% FCS |
| References: |
Murray LJ et al. 1985. Clin. Exp. Immunol. 59:315-326.  |
| Notes: |
- |
For further information about antibodies from CRT or to discuss sales or licensing options, please contact us at reagents@cancertechnology.com
Please note that CRT supplies to distributors only. However, we are happy to direct researchers to the appropriate commercial party to obtain antibodies within our portfolio. Click here to view disclaimer information. |
